ATOM.NASDAQAtomera INC

10-K: Atomera Inc. Reports Minimal Revenue in 2024, Focus Remains on Commercializing MST Technology

Sentiment:

Annual Results


Atomera Inc.'s 2024 10-K filing reveals ongoing efforts to commercialize its MST technology amidst continued operating losses and reliance on equity financing.

Delay expectedThe document mentions delays in completing the processing of evaluation wafers by customers due to tight capacity conditions.
Capital raiseThe company may require additional capital prior to obtaining a royalty-based license or prior to such a license generating sufficient royalty income to cover ongoing operating expenses.The company has an ATM facility in place and may seek additional funds through various financing sources, including follow-on equity offerings and debt financing.
Worse than expectedRevenue decreased from $550,000 in 2023 to $135,000 in 2024.Net losses remained significant at $18.4 million in 2024.

Summary

  • Atomera Incorporated's 10-K filing for the year ended December 31, 2024, highlights the company's focus on developing and commercializing its Mears Silicon Technology (MST) for the semiconductor industry.
  • The company's business model centers around licensing MST to foundries, IDMs, and fabless semiconductor manufacturers, generating revenue through license fees and royalties.
  • Revenue for 2024 was approximately $135,000, primarily from MSTcad licensing, related consulting, and engineering services, a decrease from $550,000 in 2023.
  • Atomera incurred net losses of approximately $18.4 million in 2024 and $19.8 million in 2023, with operations using approximately $13.2 million and $14.6 million of cash, respectively.
  • As of December 31, 2024, Atomera had cash, cash equivalents, and short-term investments of approximately $26.8 million and working capital of approximately $23.5 million.
  • The company believes its available working capital is sufficient to fund its current business plans for at least the next 12 months.
  • Atomera is actively engaged with 14 different engagements in the integration phase and two engagements in the process installation phase.
  • The company is working with OEMs to optimize MST deposition using their manufacturing tools.
  • Atomera is subject to risks including limited revenue generation, continued operating losses, reliance on royalty-based business model, and the need for additional financing.
  • The company is also exposed to risks related to intellectual property protection, competition, and unfavorable geopolitical and macroeconomic developments.
  • New employment agreements were entered into with key executives in March 2025.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While Atomera is making progress in commercializing its technology and has sufficient capital for the near term, it continues to face significant challenges, including limited revenue generation, ongoing operating losses, and reliance on equity financing. The company's success is highly dependent on future events and market conditions.

Positives

  • Atomera has a licensing agreement with ST Microelectronics, its first full commercial license.
  • The company is actively engaged with multiple customers in various stages of MST integration.
  • Atomera is working with OEMs to optimize MST deposition using their manufacturing tools.
  • The company believes its available working capital is sufficient to fund its current business plans for at least the next 12 months.
  • The company has successfully deposited MST using tools made by each of the leading epitaxial deposition equipment suppliers.

Negatives

  • Atomera has generated limited revenue to date.
  • The company has a history of significant operating losses and anticipates continued operating losses for at least the near term.
  • The long-term success of the business is dependent on a royalty-based business model, which is inherently risky.
  • The company may need additional financing to execute its business plan and fund operations.
  • The company lost access to certain semiconductor manufacturing and engineering services which may be difficult and/or costly to replace.

Risks

  • The timing and success of Atomera's plan of commercialization is uncertain.
  • The company's ability to replicate the benefits of MST technology on a large commercial scale is not assured.
  • Atomera's ability to structure, negotiate and enforce license agreements that will allow it to operate profitably is not guaranteed.
  • The company's success is dependent upon the adoption of its MST technology through to commercial production by at least one IDM, foundry, or fabless semiconductor manufacturer.
  • Unfavorable geopolitical and macroeconomic developments could adversely affect Atomera's business, financial condition or results of operations.
  • The company's revenues may be concentrated in a few customers and if it loses any of these customers, or these customers do not pay, its revenues could be materially adversely affected.
  • It may be difficult for Atomera to verify royalty amounts owed to it under its licensing agreements, and this may cause it to lose revenues.
  • The company could be subject to risks caused by misappropriation, misuse, leakage, falsification or intentional or accidental release or loss of information maintained in the information systems and networks of our company and our vendors, including personal or confidential information of our employees, customers and vendors.

Future Outlook

Atomera believes that its available working capital is sufficient to fund its presently forecasted working capital requirements for, at least, the next 12 months following the date of the filing of this report. The company's future capital requirements and the adequacy of its available funds will depend on many factors, including its ability to successfully commercialize its MST technology.

Industry Context

The semiconductor industry is highly competitive and characterized by rapid technological advancements. Atomera's MST technology aims to address key engineering challenges in the industry, such as increasing transistor speed, reliability, and power efficiency. The company's success depends on its ability to gain market acceptance and compete effectively with other technologies and solutions.

Comparison to Industry Standards

  • The document does not provide a direct comparison to industry standards in terms of specific financial metrics or performance benchmarks.
  • However, it mentions that Atomera's MST technology aims to improve transistor performance, which is a key area of focus for semiconductor companies.
  • Comparable companies in the semiconductor IP licensing space include ARM Holdings (though now private), Imagination Technologies, and CEVA, Inc.
  • These companies generate revenue through licensing their IP to semiconductor manufacturers and system companies.
  • Atomera's success will depend on its ability to achieve similar levels of market penetration and revenue generation as these established players.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President and Chief Executive OfficerNAScott Bibaud2025-03-03New employment agreement
Chief Financial OfficerNAFrancis Laurencio2025-03-03New employment agreement
Chief Technology OfficerNARobert Mears2025-03-03New employment agreement

Related Party Transactions

  • On April 28, 2024, the Company sold 2,247 shares of its common stock to the Chief Executive Officer, Scott Bibaud, at a price of $4.45 per share, which was determined to be the fair market value on the date of the transaction.

Stakeholder Impact

  • Shareholders: The company's continued operating losses and reliance on equity financing may negatively impact shareholder value.
  • Employees: The company's ability to attract and retain qualified employees depends on its financial stability and growth prospects.
  • Customers: The company's success in commercializing MST technology will benefit customers by providing them with improved semiconductor performance.
  • Suppliers: The company's financial condition and business prospects will impact its ability to meet its obligations to suppliers.

Next Steps

  • Continue to engage with customers in various stages of MST integration.
  • Work with OEMs to optimize MST deposition using their manufacturing tools.
  • Seek additional financing if needed to execute the business plan.
  • Focus on commercializing MST technology and generating revenue through license fees and royalties.

Key Dates

DateDescription
2001-11-26Atomera was organized as Nanovis LLC.
2007-03-13Converted to a Delaware corporation under the name Mears Technologies, Inc.
2016-01-12Changed name to Atomera Incorporated.
2017-03The 2007 Equity Incentive Plan expired.
2017-05Established the 2017 Stock Incentive Plan.
2018-09Entered into a license agreement with AKM.
2018-10Entered into a license agreement with ST Microelectronics.
2019-10Entered into a license agreement with a leading RF semiconductor supplier.
2020-12Announced availability of MSTcad software.
2021-08Entered into a five-year lease for an Applied Materials Centura epitaxial deposition reactor.
2021-12Entered into a JDA with a leading semiconductor manufacturer.
2022-02Entered into an integration license agreement with a semiconductor foundry.
2022-04Entered into a JDA with a major semiconductor foundry.
2022-05-31Entered into an Equity Distribution Agreement with Oppenheimer & Co. Inc and Craig-Hallum Capital Group LLC.
2023-04Entered into a license agreement with ST Microelectronics.
2023-05Established the 2023 Stock Incentive Plan.
2023-08TSI was acquired by Robert Bosch Semiconductor LLC.
2023-10Bosch advised that on January 31, 2024 it would cease providing engineering and manufacturing services to third parties, including Atomera.
2023-Q4Completed the first major milestone under the ST license agreement.
2024-01-31Lost access to certain semiconductor manufacturing and engineering services from TSI.
2025-02-28As of this date, there were 30,703,865 shares of the registrants common stock outstanding.
2025-03-03Entered into employment agreements with Scott Bibaud, Francis Laurencio, and Robert Mears.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.